NCT06976853View on ClinicalTrials.gov

Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 13, 2025

Primary Completion Date

May 31, 2028

Study Completion Date

August 31, 2028

Conditions
Crohn Disease (CD)
Interventions
DRUG

Tirzepatide

Addition of tirzepatide to current biological therapy

DRUG

Standard of care treatment

Intervention will be to change patient's current therapy to a 3rd or later advanced biologic patient have never been exposed to

Trial Locations (3)

10029

RECRUITING

Icahn School of Medicine at Mount Sinai, New York

63110

RECRUITING

Washington University School of Medicine, St Louis

90211

NOT_YET_RECRUITING

Cedars-Sinai Medical Center, Beverly Hills

All Listed Sponsors
lead

Washington University School of Medicine

OTHER